Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 2003; Volume 305,Issue 3

ANNOUNCEMENTS

  • You have access
    Announcement
    Brian M. Cox
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 799;

PERSPECTIVES IN PHARMACOLOGY

  • You have access
    Sources and Significance of Plasma Levels of Catechols and Their Metabolites in Humans
    David S. Goldstein, Graeme Eisenhofer and Irwin J. Kopin
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 800-811; DOI: https://doi.org/10.1124/jpet.103.049270

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

  • You have access
    Examination of the Functional Activity of P-glycoprotein in the Rat Placental Barrier Using Rhodamine 123
    Petr Pavek, Frantisek Staud, Zdenek Fendrich, Hana Sklenarova, Antonin Libra, Martina Novotna, Martin Kopecky, Milan Nobilis and Vladimir Semecky
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1239-1250; DOI: https://doi.org/10.1124/jpet.102.048470
  • You have access
    In Vivo CYP3A4 Heteroactivation Is a Possible Mechanism for the Drug Interaction between Felbamate and Carbamazepine
    Ann-Charlotte Egnell, Brian Houston and Scott Boyer
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1251-1262; DOI: https://doi.org/10.1124/jpet.102.047530

BEHAVIORAL PHARMACOLOGY

  • You have access
    Modulation of Oral Morphine Antinociceptive Tolerance and Naloxone-Precipitated Withdrawal Signs by Oral Δ9-Tetrahydrocannabinol
    Diana L. Cichewicz and Sandra P. Welch
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 812-817; DOI: https://doi.org/10.1124/jpet.102.046870
  • You have access
    Use of Irreversible Antagonists to Determine the Relative Efficacy of μ-Opioids in a Pigeon Drug Discrimination Procedure: Comparison of β-Funaltrexamine and Clocinnamox
    Andrew C. Barrett, Eric S. Smith and Mitchell J. Picker
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1061-1070; DOI: https://doi.org/10.1124/jpet.102.047068
  • You have access
    Chronopharmacology of Analgesic Effect and Its Tolerance Induced by Morphine in Mice
    Miyako Yoshida, Shigehiro Ohdo, Hiroshi Takane, Yuki Tomiyoshi, Ayaka Matsuo, Eiji Yukawa and Shun Higuchi
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1200-1205; DOI: https://doi.org/10.1124/jpet.103.049031

CARDIOVASCULAR

  • You have access
    Angiotensin II Type 1 Receptor Antagonists Inhibit Basal As Well As Low-Density Lipoprotein and Platelet-Activating Factor-Stimulated Human Monocyte Chemoattractant Protein-1
    Julie M. Proudfoot, Kevin D. Croft, Ian B. Puddey and Lawrence J. Beilin
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 846-853; DOI: https://doi.org/10.1124/jpet.102.047795
  • You have access
    Cyclosporine Induces Progressive Attenuation of Baroreceptor Heart Rate Response and Cumulative Pressor Response in Conscious Unrestrained Rats
    Hossam A. Shaltout and Abdel A. Abdel-Rahman
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 966-973; DOI: https://doi.org/10.1124/jpet.102.048447
  • You have access
    Streptozotocin-Induced Diabetes Increases Disulfide Bond Formation on Cardiac Ryanodine Receptor (RyR2)
    Keshore R. Bidasee, Karuna Nallani, Henry R. Besch and U. Deniz Dincer
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 989-998; DOI: https://doi.org/10.1124/jpet.102.046201
  • You have access
    Cytosolic Ca2+ and Phosphoinositide Hydrolysis Linked to Constitutively Active α1d-Adrenoceptors in Vascular Smooth Muscle
    Regina Gisbert, Francisco Pérez-Vizcaino, Angel L. Cogolludo, María Antonia Noguera, María Dolores Ivorra, Juan Tamargo and Pilar D'Ocon
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1006-1014; DOI: https://doi.org/10.1124/jpet.102.046169
  • You have access
    Differential Cardiovascular Regulatory Activities of the α1B- and α1D-Adrenoceptor Subtypes
    Dan Chalothorn, Dan F. McCune, Stephanie E. Edelmann, Kimimasa Tobita, Bradley B. Keller, Robert D. Lasley, Dianne M. Perez, Akito Tanoue, Gozoh Tsujimoto, Ginell R. Post and Michael T. Piascik
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1045-1053; DOI: https://doi.org/10.1124/jpet.102.048553
  • You have access
    Vasodilatory and Electrophysiological Actions of 8-iso-Prostaglandin E2 in Porcine Coronary Artery
    Y. Zhang, T. Tazzeo, S. Hirota and L. J. Janssen
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1054-1060; DOI: https://doi.org/10.1124/jpet.103.049353
  • You have access
    AGI-1067: A Multifunctional Phenolic Antioxidant, Lipid Modulator, Anti-Inflammatory and Antiatherosclerotic Agent
    Cynthia L. Sundell, Patricia K. Somers, Charles Q. Meng, Lee K. Hoong, Ki-Ling Suen, Russell R. Hill, Laura K. Landers, Angela Chapman, Dustie Butteiger, Moira Jones, David Edwards, Alan Daugherty, Martin A. Wasserman, R. Wayne Alexander, Russell M. Medford and Uday Saxena
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1116-1123; DOI: https://doi.org/10.1124/jpet.102.048132
  • You have access
    Pb2+ Inhibition of Sympathetic α7-Nicotinic Acetylcholine Receptor-Mediated Nitrergic Neurogenic Dilation in Porcine Basilar Arteries
    Min-Liang Si and Tony Jer-Fu Lee
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1124-1131; DOI: https://doi.org/10.1124/jpet.102.046854

CELLULAR AND MOLECULAR

  • You have access
    Role of Prostaglandin I2 in the Gene Expression Induced by Mechanical Stress in Spinal Ligament Cells Derived from Patients with Ossification of the Posterior Longitudinal Ligament
    Hirotaka Ohishi, Ken-Ichi Furukawa, Koei Iwasaki, Kazumasa Ueyama, Akihiro Okada, Shigeru Motomura, Seiko Harata and Satoshi Toh
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 818-824; DOI: https://doi.org/10.1124/jpet.102.047142
  • You have access
    Suppression of Cytochrome P450 3A Protein Levels by Proteasome Inhibitors
    Richard C. Zangar, Thomas A. Kocarek, Shang Shen, Nikki Bollinger, Michael S. Dahn and Donna W. Lee
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 872-879; DOI: https://doi.org/10.1124/jpet.102.044628
  • You have access
    Ligand-Selective Activation of μ-Opioid Receptor: Demonstrated with Deletion and Single Amino Acid Mutations of Third Intracellular Loop Domain
    Vipa Chaipatikul, Horace H. Loh and P. Y. Law
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 909-918; DOI: https://doi.org/10.1124/jpet.102.046219
  • You have access
    Peroxisome Proliferator-Activated Receptor Ligands Affect Growth-Related Gene Expression in Human Leukemic Cells
    Stefano Laurora, Stefania Pizzimenti, Federica Briatore, Alessandra Fraioli, Maddalena Maggio, Patrizia Reffo, Carlo Ferretti, Mario Umberto Dianzani and Giuseppina Barrera
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 932-942; DOI: https://doi.org/10.1124/jpet.103.049098
  • You have access
    Insulin Mimetic Action of Synthetic Phosphorylated Peptide Inhibitors of Glycogen Synthase Kinase-3
    Batya Plotkin, Oksana Kaidanovich, Ilana Talior and Hagit Eldar-Finkelman
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 974-980; DOI: https://doi.org/10.1124/jpet.102.047381
  • You have access
    Dissimilar Pharmacological Responses by a New Series of Imidazoline Derivatives at Precoupled and Ligand-Activated α2A-Adrenoceptor States: Evidence for Effector Pathway-Dependent Differential Antagonism
    Petrus J. Pauwels, Isabelle Rauly and Thierry Wurch
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1015-1023; DOI: https://doi.org/10.1124/jpet.102.048215
  • You have access
    Multiple Differences in Agonist and Antagonist Pharmacology between Human and Guinea Pig Histamine H1-Receptor
    Roland Seifert, Katharina Wenzel-Seifert, Tilmann Bürckstümmer, Heinz H. Pertz, Walter Schunack, Stefan Dove, Armin Buschauer and Sigurd Elz
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1104-1115; DOI: https://doi.org/10.1124/jpet.103.049619
  • You have access
    Functional Properties of Homomeric, Human α7-Nicotinic Acetylcholine Receptors Heterologously Expressed in the SH-EP1 Human Epithelial Cell Line
    Lingke Zhao, Yen-Ping Kuo, Andrew A. George, Jian-Hong Peng, Madhuri Singh Purandare, Katherine M. Schroeder, Ronald J. Lukas and Jie Wu
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1132-1141; DOI: https://doi.org/10.1124/jpet.103.048777
  • You have access
    Antiangiogenic Effect of KR-31372 by Apoptosis via Mediation of Mitochondrial KATP Channel Opening and the Phosphatase and Tensin Homolog Deleted from Chromosome 10 Phosphorylation
    Ki Young Kim, Yung Woo Shin, Sun-Ok Kim, Hong Lim, Sung-Eun Yoo and Ki Whan Hong
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1142-1149; DOI: https://doi.org/10.1124/jpet.103.048819
  • You have access
    Nucleotide-Induced Restoration of Conjunctival Chloride and Fluid Secretion in Adenovirus Type 5-Infected Pigmented Rabbit Eyes
    Ashutosh A. Kulkarni, Melvin D. Trousdale, Douglas Stevenson, Hovhannes J. Gukasyan, Michael H. I. Shiue, Kwang-Jin Kim, Russell W. Read and Vincent H. L. Lee
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1206-1211; DOI: https://doi.org/10.1124/jpet.103.049221

CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY

  • You have access
    Pharmacodynamic-Mediated Effects of the Angiogenesis Inhibitor SU5416 on the Tumor Disposition of Temozolomide in Subcutaneous and Intracerebral Glioma Xenograft Models
    Jianguo Ma, Shaolan Li, Karin Reed, Ping Guo and James M. Gallo
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 833-839; DOI: https://doi.org/10.1124/jpet.102.048587
  • You have access
    Kinetics of NAD(P)H:Quinone Oxidoreductase I (NQO1) Inhibition by Mitomycin C in Vitro and in Vivo
    Daniel L. Gustafson, David Siegel, Jeffrey C. Rastatter, Andrea L. Merz, Jacqueline C. Parpal, Jadwiga K. Kepa, David Ross and Michael E. Long
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1079-1086; DOI: https://doi.org/10.1124/jpet.103.050070

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

  • You have access
    Nitric Oxide Production Modulates Cyclosporin A-Induced Distal Renal Tubular Acidosis in the Rat
    Shuichi Tsuruoka, George J. Schwartz, Michi Wakaumi, Kenta Nishiki, Hisashi Yamamoto, Jeffrey M. Purkerson and Akio Fujimura
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 840-845; DOI: https://doi.org/10.1124/jpet.102.048207
  • You have access
    Prevention of Alterations in Intestinal Permeability Is Involved in Zinc Inhibition of Acute Ethanol-Induced Liver Damage in Mice
    Jason C. Lambert, Zhanxiang Zhou, Lipeng Wang, Zhenyuan Song, Craig J. Mcclain and Y. James Kang
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 880-886; DOI: https://doi.org/10.1124/jpet.102.047852
  • You have access
    Pharmacological Characterization of the Novel Histamine H3-Receptor Antagonist N-(3,5-Dichlorophenyl)-N′-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687)
    Robbie L. Mcleod, Charlie A. Rizzo, Robert E. West, Robert Aslanian, Kevin Mccormick, Matthew Bryant, Yunsheng Hsieh, Walter Korfmacher, Garfield G. Mingo, LoriAnn Varty, Shirley M. Williams, Neng-Yang Shih, Robert W. Egan and John A. Hey
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1037-1044; DOI: https://doi.org/10.1124/jpet.103.049254
  • You have access
    Contribution of Organic Anion Transporters to the Renal Uptake of Anionic Compounds and Nucleoside Derivatives in Rat
    Maki Hasegawa, Hiroyuki Kusuhara, Hitoshi Endou and Yuichi Sugiyama
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1087-1097; DOI: https://doi.org/10.1124/jpet.102.046847
  • You have access
    Melphalan Antitumor Efficacy and Hepatotoxicity: The Effect of Variable Infusion Duration in the Hepatic Artery
    Joost Rothbarth, Ruud A. Woutersen, Rolf W. Sparidans, Cornelis J. H. van de Velde and Gerard J. Mulder
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1098-1103; DOI: https://doi.org/10.1124/jpet.103.049379
  • You have access
    A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo
    Minoru Satoh, Naoki Kashihara, Sohachi Fujimoto, Hideyuki Horike, Takehiko Tokura, Tamehachi Namikoshi, Tamaki Sasaki and Hirofumi Makino
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1183-1190; DOI: https://doi.org/10.1124/jpet.102.047522
  • You have access
    Role of Cyclooxygenase-1 and -2, Phospholipase C, and Protein Kinase C in Prostaglandin-Mediated Gastroprotection
    Brigitta M. Peskar, Nadia Sawka, Karlheinz Ehrlich and Bernhard A. Peskar
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1233-1238; DOI: https://doi.org/10.1124/jpet.103.049650

INFLAMMATION AND IMMUNOPHARMACOLOGY

  • You have access
    A Diarylheptanoid from Lesser Galangal (Alpinia officinarum) Inhibits Proinflammatory Mediators via Inhibition of Mitogen-Activated Protein Kinase, p44/42, and Transcription Factor Nuclear Factor-κB
    Prem N. Yadav, Zhihua Liu and Mohamed M. Rafi
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 925-931; DOI: https://doi.org/10.1124/jpet.103.049171
  • You have access
    Phenyl N-tert-Butylnitrone Down-Regulates Interleukin-1β-Stimulated Matrix Metalloproteinase-13 Gene Expression in Human Chondrocytes: Suppression of c-Jun NH2-Terminal Kinase, p38-Mitogen-Activated Protein Kinase and Activating Protein-1
    Salahuddin Ahmed, Ayesha Rahman, Absarul Hasnain, Victor M. Goldberg and Tariq M. Haqqi
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 981-988; DOI: https://doi.org/10.1124/jpet.102.048611
  • You have access
    An Assessment of the Mechanistic Differences Between Two Integrin α4β1 Inhibitors, the Monoclonal Antibody TA-2 and the Small Molecule BIO5192, in Rat Experimental Autoimmune Encephalomyelitis
    D. R. Leone, K. Giza, A. Gill, B. M. Dolinski, W. Yang, S. Perper, D. M. Scott, W.-C. Lee, M. Cornebise, K. Wortham, C. Nickerson-Nutter, L. L. Chen, D. LePage, J. C. Spell, E. T. Whalley, R. C. Petter, S. P. Adams, R. R. Lobb and R. B. Pepinsky
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1150-1162; DOI: https://doi.org/10.1124/jpet.102.047332
  • You have access
    Histamine H4 Receptor Mediates Chemotaxis and Calcium Mobilization of Mast Cells
    Claudia L. Hofstra, Pragnya J. Desai, Robin L. Thurmond and Wai-Ping Fung-Leung
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1212-1221; DOI: https://doi.org/10.1124/jpet.102.046581
  • You have access
    Enhancement of Cytokine Production and AP-1 Transcriptional Activity in T Cells by Thalidomide-Related Immunomodulatory Drugs
    Peter H. Schafer, Anita K. Gandhi, Michelle A. Loveland, Roger S. Chen, Hon-Wah Man, Paul P. M. Schnetkamp, Gregor Wolbring, Sowmya Govinda, Laura G. Corral, Faribourz Payvandi, George W. Muller and David I. Stirling
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1222-1232; DOI: https://doi.org/10.1124/jpet.102.048496

NEUROPHARMACOLOGY

  • You have access
    Prolactin Releasing Peptide Has High Affinity and Efficacy at Neuropeptide FF2 Receptors
    Mia Engström, Annika Brandt, Siegfried Wurster, Juha-Matti Savola and Pertti Panula
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 825-832; DOI: https://doi.org/10.1124/jpet.102.047118
  • You have access
    GABAA Receptor α1 and β2 Subunit Null Mutant Mice: Behavioral Responses to Ethanol
    Y. A. Blednov, D. Walker, H. Alva, K. Creech, G. Findlay and R. A. Harris
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 854-863; DOI: https://doi.org/10.1124/jpet.103.049478
  • You have access
    The γ-Secretase Inhibitor N-[N-(3,5-Difluorophenacetyl)-l-alanyl]-S-phenylglycine t-butyl Ester Reduces Aβ Levels in Vivo in Plasma and Cerebrospinal Fluid in Young (Plaque-Free) and Aged (Plaque-Bearing) Tg2576 Mice
    Thomas A. Lanz, Carol S. Himes, Giovanni Pallante, Lisa Adams, Shinji Yamazaki, Ben Amore and Kalpana M. Merchant
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 864-871; DOI: https://doi.org/10.1124/jpet.102.048280
  • You have access
    Two Novel and Selective Nonimidazole Histamine H3 Receptor Antagonists A-304121 and A-317920: I. In Vitro Pharmacological Effects
    Timothy A. Esbenshade, Kathleen M. Krueger, Thomas R. Miller, Chae Hee Kang, Lynne I. Denny, David G. Witte, Betty B. Yao, Gerard B. Fox, Ramin Faghih, Youssef L. Bennani, Michael Williams and Arthur A. Hancock
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 887-896; DOI: https://doi.org/10.1124/jpet.102.047183
  • You have access
    Two Novel and Selective Nonimidazole H3 Receptor Antagonists A-304121 and A-317920: II. In Vivo Behavioral and Neurophysiological Characterization
    Gerard B. Fox, Jia Bao Pan, Richard J. Radek, Angela M. Lewis, R. Scott Bitner, Timothy A. Esbenshade, Ramin Faghih, Youssef L. Bennani, Michael Williams, Betty B. Yao, Michael W. Decker and Arthur A. Hancock
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 897-908; DOI: https://doi.org/10.1124/jpet.102.047241
  • You have access
    Nonopioid Actions of U50,488 Enantiomers Contribute to Their Peripheral Cutaneous Antinociceptive Effects
    S. K. Joshi and G. F. Gebhart
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 919-924; DOI: https://doi.org/10.1124/jpet.103.049023
  • You have access
    Novel Isoquinolinone-Derived Inhibitors of Poly(ADP-ribose) Polymerase-1: Pharmacological Characterization and Neuroprotective Effects in an in Vitro Model of Cerebral Ischemia
    Alberto Chiarugi, Elena Meli, Maura Calvani, Roberta Picca, Roberto Baronti, Emidio Camaioni, Gabriele Costantino, Maura Marinozzi, Domenico E. Pellegrini-Giampietro, Roberto Pellicciari and Flavio Moroni
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 943-949; DOI: https://doi.org/10.1124/jpet.103.048934
  • You have access
    Allosteric Adenosine Receptor Modulation Reduces Hypersensitivity Following Peripheral Inflammation by a Central Mechanism
    Xinhui Li, Dawn Conklin, Hui-Lin Pan and James C. Eisenach
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 950-955; DOI: https://doi.org/10.1124/jpet.102.047951
  • You have access
    Calcium-Dependent Inhibition of Synaptosomal Serotonin Transport by the α2-Adrenoceptor Agonist 5-Bromo-N-[4,5-dihydro-1H-imidazol-2-yl]-6-quinoxalinamine (UK14304)
    Twum-Ampofo Ansah, Sammanda Ramamoorthy, Sylvia Montañez, Lynette C. Daws and Randy D. Blakely
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 956-965; DOI: https://doi.org/10.1124/jpet.102.047134
  • You have access
    Chronic Administration of Haloperidol and Olanzapine Attenuates Ketamine-Induced Brain Metabolic Activation
    Gary E. Duncan, Seiya Miyamoto and Jeffrey A. Lieberman
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 999-1005; DOI: https://doi.org/10.1124/jpet.102.048140
  • You have access
    Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors
    Marek Samochocki, Anja Höffle, Andreas Fehrenbacher, Ruth Jostock, Jürgen Ludwig, Claudia Christner, Martin Radina, Marion Zerlin, Christoph Ullmer, Edna F. R. Pereira, Hermann Lübbert, Edson X. Albuquerque and Alfred Maelicke
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1024-1036; DOI: https://doi.org/10.1124/jpet.102.045773
  • You have access
    Nicotinic Receptors Differentially Regulate N-Methyl-d-aspartate Damage in Acute Hippocampal Slices
    P. A. Ferchmin, Dinely Perez, Vesna A. Eterovic and Jean de Vellis
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1071-1078; DOI: https://doi.org/10.1124/jpet.102.048173
  • You have access
    (+)-Fenfluramine and Its Major Metabolite, (+)-Norfenfluramine, Are Potent Substrates for Norepinephrine Transporters
    Richard B. Rothman, Robert D. Clark, John S. Partilla and Michael H. Baumann
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1191-1199; DOI: https://doi.org/10.1124/jpet.103.049684

TOXICOLOGY

  • You have access
    Roles of Necrosis, Apoptosis, and Mitochondrial Dysfunction in S-(1,2-Dichlorovinyl)-L-cysteine Sulfoxide-Induced Cytotoxicity in Primary Cultures of Human Renal Proximal Tubular Cells
    Lawrence H. Lash, David A. Putt, Sarah E. Hueni, Renee J. Krause and Adnan A. Elfarra
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1163-1172; DOI: https://doi.org/10.1124/jpet.102.046185
  • You have access
    Mechanism and Implications of Brown Adipose Tissue Proliferation in Rats and Monkeys Treated with the Thiazolidinedione Darglitazone, a Potent Peroxisome Proliferator-Activated Receptor-γ Agonist
    Michael D. Aleo, Gregg R. Lundeen, David K. Blackwell, Ward M. Smith, Gerald L. Coleman, Stanley W. Stadnicki and William M. Kluwe
    Journal of Pharmacology and Experimental Therapeutics June 2003, 305 (3) 1173-1182; DOI: https://doi.org/10.1124/jpet.102.042648
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics: 305 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 305, Issue 3
1 Jun 2003
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • ANNOUNCEMENTS
  • PERSPECTIVES IN PHARMACOLOGY
  • ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION
  • BEHAVIORAL PHARMACOLOGY
  • CARDIOVASCULAR
  • CELLULAR AND MOLECULAR
  • CHEMOTHERAPY, ANTIBIOTICS, AND GENE THERAPY
  • GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL
  • INFLAMMATION AND IMMUNOPHARMACOLOGY
  • NEUROPHARMACOLOGY
  • TOXICOLOGY
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics